Prehospital administration of blood and plasma products

Curr Opin Anaesthesiol. 2021 Aug 1;34(4):507-513. doi: 10.1097/ACO.0000000000001028.

Abstract

Purpose of review: Posttraumatic bleeding following major trauma is life threatening for the patient and remains a major global health issue. Bleeding after major trauma is worsened by trauma-induced coagulopathy (TIC). TIC consists of acute trauma coagulopathy and resuscitation coagulopathy. The early diagnosis and management of prehospital TIC management are challenging.

Recent findings: Concepts for early diagnosis and management of civilian prehospital TIC management are evolving. The feasibility of prehospital blood component as well as coagulation factor transfusion has been proven.

Summary: Due to different national guidelines and regulations of blood component therapies there is a wide heterogeneity in concepts of prehospital damage control resuscitation. Tranexamic acid administration is widely accepted, whereas the transfusion of whole blood, blood components, or coagulations factors needs further examination in the civilian setting.

Publication types

  • Review

MeSH terms

  • Blood Coagulation Disorders* / etiology
  • Blood Coagulation Disorders* / therapy
  • Blood Component Transfusion
  • Emergency Medical Services*
  • Hemorrhage / etiology
  • Hemorrhage / therapy
  • Humans
  • Resuscitation
  • Wounds and Injuries* / complications
  • Wounds and Injuries* / therapy